http://www.fpnotebook.com/
Naltrexone
Aka: Naltrexone, Trexan, Revia
- Indications
- For relapsing Alcoholic
- Must be used with an aftercare program
- Contraindications
- Long-term Opioid use or heroin dependence
- Risk of severe withdrawal
- Hepatitis
- Liver failure
- Adverse effects
- Hepatotoxicity (dose dependent)
- Nausea (10%)
- Headache
- Anxiety
- Sedation
- Mechanism
- Reduces Alcohol craving
- Efficacy
- Initial studies showed relapse reduction by 50%
- Recent large DBPCT showed no benefit with Naltrexone
- Relapse rate: 38% at 13 weeks (44% with Placebo)
- Compliance rate low: 42-44% in all groups
- Krystal (2001) N Engl J Med 345:1734-9
- Adverse effects
- No toxicity if drinking with Naltrexone
- Not indicated to make them social drinkers
- Alcoholics tend to get less drunk on Naltrexone
- Very broad safety profile with minimal adverse effects
- Hepatotoxicity, however is a risk
- Croop (1997) Arch Gen Psych 54:1130-5
- Monitoring
- Obtain serum liver transaminases periodically
- Monthly for first 3 months
- Then every 3 months
- Dosage
- Naltrexone 50 mg PO daily ($5/pill)
- May need to be used for 1 year or longer
- References
- Hartmann (1997) Am Fam Physician 55(5):1877-9
- Williams (2005) Am Fam Physician 72(9):1775-80